| VRK1 | VRK | CK1 | 3op5 | A | A | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 4870 | 1.00 | |
| CAMK2B (CaMK2b) | CAMK2 | CAMK | 3bhh | B | | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 1506 | 0.76 | |
| CAMK2B (CaMK2b) | CAMK2 | CAMK | 3bhh | A | | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 1507 | 0.76 | |
| CDK2 | CDK | CMGC | 1vyw | C | | n-(3-cyclopropyl-1h-pyrazol-5-yl)-2-(2-naphthyl)acetamide | Human | 4133 | 0.41 | |
| MAP2K7 | STE7 | STE | 6yg5 | A | | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile | Human | 12677 | 0.65 | |
| STK17B (DRAK2) | DAPK | CAMK | 3lm0 | A | A | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]-5-methylpyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 6796 | 0.70 | |
| STK17B (DRAK2) | DAPK | CAMK | 3lm0 | A | B | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]-5-methylpyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 6797 | 0.70 | |
| VRK1 | VRK | CK1 | 3op5 | C | A | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 4886 | 1.00 | |
| ACVR2A (ACTR2) | STKR | TKL | 3soc | A | B | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 2676 | 0.65 | |
| SLK | STE20 | STE | 2uv2 | A | A | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 1834 | 0.65 | |
| PAK4 | STE20 | STE | 5bms | A | | n~2~-[(7-chloro-1h-benzimidazol-6-yl)methyl]-n~4~-(5-cyclopropyl-1h-pyrazol-3-yl)pyrimidine-2,4-diamine | Human | 1389 | 0.50 | |
| CDKL3 | CDKL | CMGC | 3zdu | A | | [4-({4-[(3-cyclopentyl-1h-pyrazol-5-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 4677 | 0.70 | |
| ULK1 | ULK | Other | 4wno | A | B | n~2~-(4-aminophenyl)-n~4~-(5-cyclopropyl-1h-pyrazol-3-yl)quinazoline-2,4-diamine | Human | 1876 | 0.45 | |
| VRK1 | VRK | CK1 | 3op5 | D | B | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 4892 | 1.00 | |
| VRK2 | VRK | CK1 | 8q1z | A | B | 2-[4-[[4-[(3-~{tert}-butyl-1~{h}-pyrazol-5-yl)amino]pyrimidin-2-yl]amino]phenyl]ethanenitrile | Human | 14898 | 0.60 | |
| VRK2 | VRK | CK1 | 8q1z | A | A | 2-[4-[[4-[(3-~{tert}-butyl-1~{h}-pyrazol-5-yl)amino]pyrimidin-2-yl]amino]phenyl]ethanenitrile | Human | 14899 | 0.60 | |
| SLK | STE20 | STE | 2uv2 | A | B | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 1837 | 0.65 | |
| ACVR2A (ACTR2) | STKR | TKL | 3soc | B | A | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 2677 | 0.65 | |
| STK26 (MST4) | STE20 | STE | 3ggf | B | B | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 1804 | 0.65 | |
| ULK1 | ULK | Other | 4wno | A | A | n~2~-(4-aminophenyl)-n~4~-(5-cyclopropyl-1h-pyrazol-3-yl)quinazoline-2,4-diamine | Human | 1881 | 0.45 | |
| PAK1 | STE20 | STE | 4zy6 | B | A | n~2~-[(7-chloro-1h-benzimidazol-6-yl)methyl]-n~4~-(5-cyclopropyl-1h-pyrazol-3-yl)pyrimidine-2,4-diamine | Human | 156 | 0.50 | |
| VRK1 | VRK | CK1 | 3op5 | D | A | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 4878 | 1.00 | |
| PAK1 | STE20 | STE | 6b16 | A | | n~4~-(5-cyclopropyl-1h-pyrazol-3-yl)-n~2~-[(1s)-1-(1h-pyrrolo[3,2-b]pyridin-5-yl)ethyl]pyrimidine-2,4-diamine | Human | 8574 | 0.46 | |
| VRK1 | VRK | CK1 | 3op5 | C | B | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 4879 | 1.00 | |
| STK26 (MST4) | STE20 | STE | 3ggf | A | B | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 1808 | 0.65 | |
| CDKL5 | CDKL | CMGC | 4bgq | A | A | [4-({4-[(3-cyclopentyl-1h-pyrazol-5-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 1425 | 0.70 | |
| CDKL5 | CDKL | CMGC | 4bgq | A | B | [4-({4-[(3-cyclopentyl-1h-pyrazol-5-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 1426 | 0.70 | |
| PAK1 | STE20 | STE | 4zy6 | A | B | n~2~-[(7-chloro-1h-benzimidazol-6-yl)methyl]-n~4~-(5-cyclopropyl-1h-pyrazol-3-yl)pyrimidine-2,4-diamine | Human | 173 | 0.50 | |
| VRK1 | VRK | CK1 | 3op5 | B | A | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 4894 | 1.00 | |
| AURKA (AurA) | Aur | Other | 4j8m | A | | 1-[4-[[4-[(5-cyclopentyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl]amino]phenyl]-3-[3-(trifluoromethyl)phenyl]urea | Human | 2020 | 0.53 | |
| CDK2 | CDK | CMGC | 1vyw | A | | n-(3-cyclopropyl-1h-pyrazol-5-yl)-2-(2-naphthyl)acetamide | Human | 3992 | 0.41 | |
| CAMK2D (CaMK2d) | CAMK2 | CAMK | 2vn9 | A | | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 2140 | 0.65 | |
| CAMK2D (CaMK2d) | CAMK2 | CAMK | 2vn9 | B | | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 2139 | 0.65 | |
| ACVR2A (ACTR2) | STKR | TKL | 3soc | A | A | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 2675 | 0.65 | |
| ACVR2A (ACTR2) | STKR | TKL | 3soc | B | B | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 2685 | 0.65 | |
| PAK1 | STE20 | STE | 6b16 | B | | n~4~-(5-cyclopropyl-1h-pyrazol-3-yl)-n~2~-[(1s)-1-(1h-pyrrolo[3,2-b]pyridin-5-yl)ethyl]pyrimidine-2,4-diamine | Human | 8575 | 0.46 | |
| PAK1 | STE20 | STE | 4zy6 | B | B | n~2~-[(7-chloro-1h-benzimidazol-6-yl)methyl]-n~4~-(5-cyclopropyl-1h-pyrazol-3-yl)pyrimidine-2,4-diamine | Human | 184 | 0.50 | |
| PAK1 | STE20 | STE | 4zy5 | A | | n~2~-[(trans-4-aminocyclohexyl)methyl]-n~4~-(3-cyclopropyl-1h-pyrazol-5-yl)pyrimidine-2,4-diamine | Human | 155 | 0.41 | |
| PAK1 | STE20 | STE | 4zy5 | B | | n~2~-[(trans-4-aminocyclohexyl)methyl]-n~4~-(3-cyclopropyl-1h-pyrazol-5-yl)pyrimidine-2,4-diamine | Human | 163 | 0.41 | |
| PAK1 | STE20 | STE | 4zy6 | A | A | n~2~-[(7-chloro-1h-benzimidazol-6-yl)methyl]-n~4~-(5-cyclopropyl-1h-pyrazol-3-yl)pyrimidine-2,4-diamine | Human | 138 | 0.50 | |
| STK26 (MST4) | STE20 | STE | 3ggf | A | A | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 1807 | 0.65 | |
| STK26 (MST4) | STE20 | STE | 3ggf | B | A | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]quinazolin-2-yl}imino)cyclohexa-2,5-dien-1-yl]acetonitrile | Human | 1805 | 0.65 | |
| VRK1 | VRK | CK1 | 3op5 | B | B | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 4944 | 1.00 | |
| VRK1 | VRK | CK1 | 3op5 | A | B | [4-({4-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl}amino)phenyl]acetonitrile | Human | 4942 | 1.00 | |